- Report
- October 2024
- 450 Pages
Global
From €3947EUR$3,995USD£3,285GBP
- Report
- October 2024
- 500 Pages +
Global
From €3947EUR$3,995USD£3,285GBP
- Report
- April 2024
- 293 Pages
Global
From €4742EUR$4,799USD£3,947GBP
- Report
- June 2024
- 76 Pages
Global
From €1383EUR$1,400USD£1,151GBP
- Report
- February 2024
- 322 Pages
Global
From €5409EUR$5,666USD£4,350GBP
- Report
- July 2024
- 288 Pages
Global
From €5409EUR$5,666USD£4,350GBP
- Report
- August 2024
- 195 Pages
Global
From €2371EUR$2,400USD£1,974GBP
- Report
- September 2024
- 210 Pages
Global
From €2964EUR$3,000USD£2,467GBP
- Report
- August 2024
- 1200 Pages
Global
From €4150EUR$4,200USD£3,454GBP
- Report
- June 2024
- 140 Pages
Global
From €2964EUR$3,000USD£2,467GBP
- Report
- May 2024
- 100 Pages
Global
From €3261EUR$3,300USD£2,714GBP
- Report
- January 2024
- 485 Pages
Global
From €4595EUR$4,650USD£3,824GBP
- Report
- March 2024
Global
From €4792EUR$4,850USD£3,989GBP
- Report
- August 2024
- 265 Pages
Global
From €2421EUR$2,450USD£2,015GBP
- Report
- January 2024
- 200 Pages
Global
From €4940EUR$5,000USD£4,112GBP
- Report
- October 2024
- 197 Pages
Global
From €3503EUR$3,545USD£2,915GBP
€3892EUR$3,939USD£3,239GBP
- Report
- October 2024
- 188 Pages
Global
From €3503EUR$3,545USD£2,915GBP
€3892EUR$3,939USD£3,239GBP
- Report
- November 2024
- 197 Pages
Global
From €3503EUR$3,545USD£2,915GBP
€3892EUR$3,939USD£3,239GBP
- Report
- November 2024
- 194 Pages
Global
From €3503EUR$3,545USD£2,915GBP
€3892EUR$3,939USD£3,239GBP
- Report
- October 2024
- 196 Pages
Global
From €3503EUR$3,545USD£2,915GBP
€3892EUR$3,939USD£3,239GBP
The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more